160321 - AMA Guidelines on Doctors' Relationship with Industry
It is important that doctors (medical practitioners) and industry work collaboratively to improve the quality of, and access to, health care through the development of and access to new and improved therapeutic products, treatments and services.
In 2018, the AMA released guidelines to assist doctors with understanding their responsibilities when working with industry.
The AMA Guidelines on Doctors’ Relationships with Industry 2018 serves to assist you to appropriately identify and manage your working arrangements with industry.
Relationships between doctors and industry can take many forms, including being involved in industry-sponsored research involving patients, and post-marketing surveillance studies. Doctors may also attend scientific, educational, and continuing professional development meetings sponsored or supported by industry. Doctors may hold industry shares or similar options, or hold intellectual property rights in a medical device or similar product. Doctors may also receive product samples, dispense products, or meet with industry representatives. Doctors are a major focus of industry marketing, as many products require a prescription before being dispensed, and direct-to-consumer advertising of prescription medicines is banned in Australia. Medical schools and other education bodies should be open and transparent about educational sessions provided by industry, and it should not be compulsory for medical students to attend any sessions or activities organised by industry.Learning outcomes